Pacific Biosciences of California, Inc. (PACB)
Pacific Biosciences of California, Inc. (PACB) is a Healthcare stock tracked by StreetAlpha. It last closed at $2.46 on Oct 1. PACB reports earnings on Tue, Nov 3, 2026. Over the past 90 days StreetAlpha recorded 2 whale options trades in PACB, 0% of them bullish and 100% bearish. In the past 30 days there were 4 dark pool prints totaling $645K, the largest $215K.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →Based on 1 analyst who set a price target on PACB in the past 90 days. The average target is $1.35, with a high of $1.35 and a low of $1.35, compared with the last close of $2.46.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 9 | UBS | Assumed coverage | Hold | $1.35 |
| Mar 6 | Barclays | Downgrade | Sell | $1.50 |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PACB is in one of them and how their past PACB trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered PACB in an article yet. Here's the latest on the wider market.
For informational purposes only. Not financial advice. Options flow and dark pool data are delayed and may be incomplete.